Sale!

Liquid Biopsy Colon Cancer Test

Original price was: $1,000.Current price is: $826.

-17%

The Liquid Biopsy Colon Cancer Test is a revolutionary non-invasive blood test that detects circulating tumor DNA (ctDNA) for early colon cancer screening. Using advanced Next-Generation Sequencing (NGS) technology, this test analyzes genetic markers in blood samples to identify colorectal cancer at its earliest stages. Priced at $826 USD (regularly $1000), this innovative screening method provides a comfortable alternative to traditional colonoscopies. The test is particularly beneficial for individuals with family history of colon cancer, those experiencing gastrointestinal symptoms, or anyone seeking proactive cancer screening. Results are available within 21 working days, providing comprehensive genetic insights for personalized healthcare decisions and early intervention strategies.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Liquid Biopsy Colon Cancer Test

Revolutionary Early Detection for Colorectal Cancer

The Liquid Biopsy Colon Cancer Test represents a groundbreaking advancement in cancer screening technology. This non-invasive blood test utilizes cutting-edge Next-Generation Sequencing (NGS) to detect circulating tumor DNA (ctDNA) in the bloodstream, providing early warning signs of colorectal cancer development. Unlike traditional screening methods that require invasive procedures, this innovative approach offers a comfortable, convenient alternative for comprehensive cancer monitoring.

What This Test Measures and Detects

Our Liquid Biopsy Colon Cancer Test specifically analyzes:

  • Circulating tumor DNA (ctDNA) fragments released by colon cancer cells
  • Genetic mutations associated with colorectal cancer development
  • Biomarkers indicating early-stage tumor formation
  • Epigenetic modifications linked to cancer progression
  • Specific genetic alterations in key oncogenes and tumor suppressor genes

Advanced NGS Technology

Using state-of-the-art Next-Generation Sequencing, our test provides unparalleled sensitivity in detecting minute quantities of cancer-related DNA. This technology enables the identification of genetic abnormalities long before physical symptoms manifest or tumors become visible through conventional imaging methods.

Who Should Consider This Test

This advanced screening is particularly recommended for individuals experiencing:

  • Unexplained changes in bowel habits lasting more than a few days
  • Persistent abdominal discomfort, cramps, or pain
  • Rectal bleeding or blood in stool
  • Unexplained weight loss and fatigue
  • Family history of colorectal cancer or polyps
  • Personal history of inflammatory bowel disease
  • Individuals over 45 seeking routine cancer screening
  • Those with genetic syndromes increasing colon cancer risk

Significant Benefits of Liquid Biopsy Testing

Early Detection Advantage

Early detection through liquid biopsy can significantly improve treatment outcomes and survival rates. By identifying cancer at its earliest stages, patients have access to less invasive treatment options and better prognosis.

Non-Invasive Procedure

Unlike traditional colonoscopies that require bowel preparation and sedation, our liquid biopsy requires only a simple blood draw using Streck tubes, making it accessible to patients who may avoid conventional screening methods.

Comprehensive Genetic Insights

The test provides detailed genetic information that can guide personalized treatment strategies and help monitor treatment response over time.

Convenient Monitoring

Regular testing allows for ongoing monitoring of cancer risk and early detection of recurrence, providing continuous peace of mind for patients and their healthcare providers.

Understanding Your Test Results

Your results will be presented in a comprehensive report that includes:

  • Negative Result: No detectable ctDNA or cancer-associated mutations were found, indicating low current risk for colorectal cancer
  • Positive Result: Detection of cancer-related genetic markers, requiring follow-up with your healthcare provider for additional evaluation
  • Variant of Unknown Significance: Genetic changes detected that require further clinical correlation
  • Quantitative Analysis: Measurement of ctDNA levels to assess disease burden and monitor progression

All positive results should be discussed with your healthcare provider for appropriate follow-up care, which may include additional diagnostic procedures like colonoscopy for confirmation.

Test Pricing and Details

Test Feature Details
Test Name Liquid Biopsy Colon Cancer Test
Regular Price $1000 USD
Discount Price $826 USD
Turnaround Time 21 Working Days
Sample Type Blood (Streck Tube)
Technology Next-Generation Sequencing (NGS)

Nationwide Availability

GGC DNA has testing facilities across the United States, with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures accessible, high-quality genetic testing services for patients throughout the country.

Take Control of Your Health Today

Don’t wait for symptoms to appear. Early detection through liquid biopsy testing can be life-saving. Our experienced team is ready to help you take the next step in proactive cancer screening.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Liquid Biopsy Colon Cancer Test and take advantage of our special pricing at only $826 USD.

Invest in your health with the most advanced colon cancer screening technology available. Book your test now and gain the peace of mind that comes with comprehensive genetic cancer risk assessment.